Hartford Funds Management Co LLC lessened its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 32.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,863 shares of the company’s stock after selling 1,861 shares during the quarter. Hartford Funds Management Co LLC’s holdings in HCA Healthcare were worth $1,650,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. BlackRock Inc. purchased a new position in HCA Healthcare during the second quarter valued at $5,069,974,000. Wellington Management Group LLP grew its position in shares of HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after buying an additional 799,761 shares during the period. Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc purchased a new position in HCA Healthcare during the 2nd quarter valued at about $410,992,000. Finally, Jupiter Topco LLC bought a new stake in HCA Healthcare during the second quarter worth about $371,138,000. 62.73% of the stock is owned by hedge funds and other institutional investors.
HCA Healthcare Stock Down 5.1%
Shares of HCA opened at $475.84 on Thursday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market capitalization of $99.40 billion, a P/E ratio of 15.77, a price-to-earnings-growth ratio of 1.67 and a beta of 1.11. The firm has a 50 day moving average of $457.97 and a 200 day moving average of $446.05.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. During the same period in the prior year, the firm posted $6.96 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.14 EPS for the current year.
HCA Healthcare Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.34%.
Insider Activity
In related news, SVP Erica Rossitto sold 3,500 shares of the stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total transaction of $1,770,335.00. Following the sale, the senior vice president directly owned 13,426 shares of the company’s stock, valued at $6,791,005.06. This trade represents a 20.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Jon Foster sold 21,713 shares of HCA Healthcare stock in a transaction dated Friday, November 6th. The stock was sold at an average price of $494.95, for a total value of $10,746,849.35. Following the completion of the sale, the chief operating officer owned 10,000 shares of the company’s stock, valued at $4,949,500. The trade was a 68.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 36,413 shares of company stock valued at $18,251,464 over the last ninety days. 1.50% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on HCA shares. Bank of America upped their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock a “neutral” rating in a report on Wednesday, October 28th. Weiss Ratings raised HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research report on Tuesday, November 10th. Oppenheimer cut their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. The Goldman Sachs Group reduced their price objective on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Finally, KeyCorp boosted their target price on HCA Healthcare from $435.00 to $490.00 and gave the stock an “overweight” rating in a report on Wednesday, October 28th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $482.30.
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Articles
- Five stocks we like better than HCA Healthcare
- From Berlin to Brussels: Tesla’s $3.3 Billion Robotaxi Gamble
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
